Answers are grounded in this paper and cite their sources.
In this small study from an equal-access setting, there was no difference in the receipt of BCG or any differences in bladder cancer outcomes according to race.
No takes yet. Share an insight, caveat, or question.
Lawler et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: